Fredun Pharmaceuticals Limited
Promoter holding in Fredun Pharmaceuticals Limited was 43.62% in Sep 2026.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Sep '26 | 43.62% | 56.38% |
Compared with similar companies
Promoter holding in Fredun Pharmaceuticals Limited is lower than 76% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Fredun Pharmaceuticals Limited | 43.62% |
| Dr. Agarwal's Eye Hospital Limited | 72.67% |
| KMC Speciality Hospitals (India) Limited | 75.00% |
| Hikal Limited | 68.85% |
| Dishman Carbogen Amcis Limited | 59.32% |
| Vimta Labs Limited | 35.67% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Fredun Pharmaceuticals Limited's promoter holding?
Promoters held 43.62% of Fredun Pharmaceuticals Limited as of 30 Sep 2026, and the public held 56.38%.
Are any promoter shares of Fredun Pharmaceuticals Limited pledged?
No promoter shares are recorded as pledged.
How does Fredun Pharmaceuticals Limited's promoter holding compare with similar companies?
Promoter holding in Fredun Pharmaceuticals Limited is lower than 76% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.